Shi, Leming

A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages

Yu, Y., Fuscoe, J. C., Zhao, C., Guo, C., Jia, M., Qing, T., Bannon, D. I., Lancashire, L., Bao, W., Du, T., et al. (2014) · Nature Communications

Genomics and Phylogenetic StudiesGene expression and cancer classification

Cited by 395

Comparison of RNA-seq and microarray-based models for clinical endpoint prediction

Zhang, W., Yu, Y., Hertwig, F., Thierry-Mieg, J., Zhang, W., Thierry-Mieg, D., Wang, J., Furlanello, C., Devanarayan, V., Cheng, J., et al. (2015) · Genome Biology

Gene expression and cancer classificationNeuroblastoma Research and Treatments

Cited by 393

Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes

Guo, L., Dial, S., Shi, L., Branham, W., Liu, J., Fang, J.-L., Green, B., Deng, H., Kaput, J., & Ning, B. (2011) · Drug Metabolism and Disposition

Pharmacogenetics and Drug MetabolismDrug-Induced Hepatotoxicity and Protection

Cited by 348

Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning

Wang, D., Zhang, C., Wang, B., Li, B., Wang, Q., Liu, D., Wang, H., Zhou, Y., Shi, L., Lan, F., et al. (2019) · Nature Communications

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 331

DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome

Luo, H., Chen, J., Shi, L., Mikailov, M., Zhu, H., Wang, K., He, L., & Yang, L. (2011) · Nucleic Acids Research

Computational Drug Discovery MethodsBioinformatics and Genomic Networks

Cited by 206

Using RNA sample titrations to assess microarray platform performance and normalization techniques

Shippy, R., Fulmer-Smentek, S., Jensen, R. V., Jones, W. D., Wolber, P. K., Johnson, C. D., Pine, P. S., Boysen, C., Guo, X., Chudin, E., et al. (2006) · Nature Biotechnology

Gene expression and cancer classificationGenomics and Phylogenetic Studies

Cited by 173